Characterisation and In Vitro Biocompatability of Polycaprolactone: Cissus Quandrangularis Electrospun Scaffold for Bone Regeneration
DOI:
https://doi.org/10.65795/3f3thv97Keywords:
polycaprolactone, cissus quadrangularis, electrospinning, bone graft, tissue engineeringAbstract
The aim of the present study is to develop an osteogenic bone graft material with an herbal component. Cissus quadrangularis, a perennial climber widely used in traditional Indian is reported to possess bone fracture healing activity. Polycaprolactone (PCL) an FDA approved biocompatible polymer and Cissus Quadrangularis (CQ) were blend and electrospun to obtain a nanofibrous scaffold. The fiber morphology was characterised by scanning electron microscopy, FT-IR, XRD and TGA. MG63 osteoblast-like cells were used to evaluate the biocompatibility using MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. The in-vitro experiment revealed that the PCL-CQ composite electrospun scaffold showed better MG63 cell adhesion and growth compared to the control PCL scaffold and thus could be a potential scaffold material for bone defect applications.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Pandurangan Harikrishnan, Kayal Vizhi Kumaravel, Arayambath Balamani, Elumalai Canmany (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright and Licensing
All articles published in Trends in Biomaterials and Artificial Organs are published Open Access. To ensure the widest possible dissemination of research while protecting the integrity of the original work, we utilize the Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) 4.0 International License.
User Rights
Under this license, the public is free to share (copy and redistribute the material in any medium or format) under the following terms:
- Attribution: Users must give appropriate credit, provide a link to the license, and indicate if changes were made.
- Non-Commercial: Users may not use the material for commercial purposes. This includes, but is not limited to, the sale of the article or its use in promotional materials for-profit.
- No Derivatives: If a user remixes, transforms, or builds upon the material, they may not distribute the modified material.
Author Rights
Authors retain copyright of their work while granting the journal a non-exclusive license to publish. Because of the NoDerivs (ND) and Non-Commercial (NC) designations:
- Third parties (such as other researchers) must seek permission from the authors/journal to include figures, tables, or portions of the text in new works or commercial publications.
- Authors may deposit the "Version of Record" in institutional repositories immediately upon publication, provided the CC BY-NC-ND 4.0 license is clearly linked.
How to Cite
Accepted 20-07-2026
Published 30-07-2026
